Therapeutic approach guided by genetic alteration: use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression.
about
Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma.Renal Medullary Carcinoma with an Aggressive Clinical Course: A Case Report and Review of the Literature.Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.Expression of Somatostatin Receptor Type 2A and PTEN in Neuroendocrine Neoplasms Is Associated with Tumor Grade but Not with Site of Origin.
P2860
Therapeutic approach guided by genetic alteration: use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Therapeutic approach guided by ...... with loss of PTEN expression.
@en
type
label
Therapeutic approach guided by ...... with loss of PTEN expression.
@en
prefLabel
Therapeutic approach guided by ...... with loss of PTEN expression.
@en
P2093
P2860
P1476
Therapeutic approach guided by ...... with loss of PTEN expression.
@en
P2093
Jacob S Lipkin
Joseph J Drabick
Mathew Kaag
Monika Joshi
Nabeel E Sarwani
Sheldon L Holder
Syed M Rizvi
Zoran Gatalica
P2860
P356
10.4161/15384047.2014.972843
P577
2015-01-01T00:00:00Z